FI48082C - Menetelmä uusien verenpainetta alentavien 2-aryylihydratsino-imidatsol iinien-(2) valmistamiseksi - Google Patents

Menetelmä uusien verenpainetta alentavien 2-aryylihydratsino-imidatsol iinien-(2) valmistamiseksi

Info

Publication number
FI48082C
FI48082C FI672082A FI208267A FI48082C FI 48082 C FI48082 C FI 48082C FI 672082 A FI672082 A FI 672082A FI 208267 A FI208267 A FI 208267A FI 48082 C FI48082 C FI 48082C
Authority
FI
Finland
Prior art keywords
arylhydrazinoimidazoline
antihypertensive
preparation
Prior art date
Application number
FI672082A
Other languages
English (en)
Swedish (sv)
Other versions
FI48082B (fi
Inventor
Staehle
Kummer
Koeppe
Zeile
Hoefke
Samtleben
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1966B0088361 external-priority patent/DE1670124B2/de
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Application granted granted Critical
Publication of FI48082B publication Critical patent/FI48082B/fi
Publication of FI48082C publication Critical patent/FI48082C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
FI672082A 1966-08-05 1967-07-31 Menetelmä uusien verenpainetta alentavien 2-aryylihydratsino-imidatsol iinien-(2) valmistamiseksi FI48082C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1966B0088361 DE1670124B2 (de) 1966-08-05 1966-08-05 2-phenylhydrazino-imidazoline-(2), verfahren zu deren herstellung sowie diese enthaltende blutdrucksenkende zubereitungen
DEB0090823 1967-01-20

Publications (2)

Publication Number Publication Date
FI48082B FI48082B (fi) 1974-02-28
FI48082C true FI48082C (fi) 1974-06-10

Family

ID=25968043

Family Applications (1)

Application Number Title Priority Date Filing Date
FI672082A FI48082C (fi) 1966-08-05 1967-07-31 Menetelmä uusien verenpainetta alentavien 2-aryylihydratsino-imidatsol iinien-(2) valmistamiseksi

Country Status (9)

Country Link
US (1) US3480630A (fi)
AT (1) AT284115B (fi)
CH (3) CH505111A (fi)
DK (1) DK118607B (fi)
FI (1) FI48082C (fi)
FR (2) FR1550151A (fi)
GB (1) GB1180794A (fi)
IL (1) IL28433A (fi)
YU (3) YU32176B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3516995A (en) * 1969-02-27 1970-06-23 Sandoz Ag Benzalhydrazones
DE2041734A1 (de) * 1970-08-22 1972-02-24 Bayer Ag Carbamate der 2-Phenylhydrazino-2-imidazoline,Verfahren zu ihrer Herstellung und ihre Verwendung als Ektoparasitizide
US4028380A (en) * 1974-06-01 1977-06-07 Akzona Incorporated Hydrazino-imidazole derivatives
NL7407469A (nl) * 1974-06-01 1975-12-03 Akzo Nv Nieuwe amidinohydrazonverbindingen.
US4117146A (en) * 1977-06-27 1978-09-26 The Dow Chemical Company Method for treating depression and anxiety using phenyl hydrazo compounds
JP2864075B2 (ja) * 1991-12-04 1999-03-03 富士写真フイルム株式会社 イミダゾールアゾ色素およびそれを含有する熱転写色素供与材料
CN101687812A (zh) 2007-07-02 2010-03-31 弗·哈夫曼-拉罗切有限公司 对痕量胺相关受体(taar)具有良好亲和性的2-咪唑啉化合物
AU2008281918A1 (en) * 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands
WO2009019149A1 (en) * 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as taar1 ligands
US9452980B2 (en) * 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
MA53755A (fr) 2016-03-17 2021-08-04 Hoffmann La Roche Dérivé de 5-éthyl-4-méthyl-pyrazole-3-carboxamide ayant une activité comme agonist de taar

Also Published As

Publication number Publication date
GB1180794A (en) 1970-02-11
CH489502A (de) 1970-04-30
DK118607B (da) 1970-09-14
US3480630A (en) 1969-11-25
CH505111A (de) 1971-03-31
IL28433A (en) 1971-06-23
YU76573A (en) 1977-12-31
FR1550151A (fi) 1968-12-20
YU153867A (en) 1973-12-31
YU73377A (en) 1982-06-30
AT284115B (de) 1970-09-10
YU32176B (en) 1974-06-30
CH497432A (de) 1970-10-15
YU33864B (en) 1978-06-30
FR7322M (fi) 1969-10-06
FI48082B (fi) 1974-02-28

Similar Documents

Publication Publication Date Title
FI48590C (fi) Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi.
SE390969B (sv) Forfarande for framstellning av 1,2,3,4-tetrahydro-7-halogen-6-sulfamyl-4-kinazolinoner
FI48062C (fi) Menetelmä ksylitolin valmistamiseksi
SE300618B (sv) Förfarande för framställning av N-fenylpropyl- N1 -fenylpiperaziner
FI48082C (fi) Menetelmä uusien verenpainetta alentavien 2-aryylihydratsino-imidatsol iinien-(2) valmistamiseksi
FI48722C (fi) Menetelmä 3-metyylipenteenien valmistamiseksi.
FI50409C (fi) Menetelmä pyridiini-karboksyylihappojen valmistamiseksi
FI50334C (fi) Menetelmä 1-hydroksi-2pyridonien valmistamiseksi.
DK131429B (da) Analogifremgangsmåde til fremstilling af derivater af 4'-demethyl-epipodophyllotoxin-beta-D-glucosid.
FI50407C (fi) Menetelmä trikloorimonosilaanien valmistamiseksi
FI47577C (fi) Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä.
FI47092C (fi) Menetelmä terapeuttisesti arvokkaiden sekasubstituoitujen 1-fenoksi-3- alkyyliaminopropanolien-(2) valmistamiseksi.
FI48724C (fi) Menetelmä N-karbamoyylioksifenyylikarbamaattien valmistamiseksi.
FI44593C (fi) Menetelmä d(-)-pantolaktonin valmistamiseksi
FI46727C (fi) Menetelmä pyridatsolijohdannaisten valmistamiseksi.
FI47358C (fi) Menetelmä terapeuttisesti käytettävän 4'-demetyyli-epipodofyllotoksiin i-beta-D-glukosidin valmistamiseksi.
SE380531B (sv) Forfarande for framstellning av 13-alkyl-1,3,5(10),6,8,14-steroidhexaener
FI49162C (fi) Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi.
NO136976C (no) Fremgangsm}te for fremstilling av 2,3-dihydrobenzodiazepiner
DK120845B (da) Fremgangsmåde til fremstilling af 3β-formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enolider.
FI48081C (fi) Menetelmä farmakologisesti aktiivisten 1-sulfanilyyli-2-imino-3-R-imid atsolidiinien valmistamiseksi
FI36690A (fi) Förfarande för framställning av 1,1-dialkylcyklohexantrionderivat
FI47988C (fi) 1,4-bentsodiatsepiinien valmistusmenetelmä
FI43436C (fi) Förfarande för framställning av 2-azetidinoner
FI34439A (fi) Förfarande för framställning av 2-halogen-delta'-androsten-17 B-ol-3-on-föreningar